ADAM17 and metabolic dysfunction-associated steatotic liver disease: Adam17 expression is tightly controlled in obesity as Adam17-knockout mice on HFD shows protection from insulin resistance, diabetes, non-alcoholic fatty liver disease and tumorigenesis (48, 49).